Blood ammonia in patients with chronic liver diseases: A better defined role in clinical practice - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Analytical Biochemistry Année : 2022

Blood ammonia in patients with chronic liver diseases: A better defined role in clinical practice

Résumé

Ammonia is one of the main players in the pathogenesis of hepatic encephalopathy (HE) in patients with chronic liver diseases. The usefulness of measuring ammonemia has been debated since many years. New data reveal that besides helping in the differential diagnosis of HE, ammonemia could be a prognostic marker not only in patients with HE, but also in patients without any neurological symptoms, suggesting a potential toxic role of ammonia beyond the brain. Finally, targeting ammonemia while monitoring therapeutic response could be a way to improve outcomes in patients with HE.
Fichier non déposé

Dates et versions

hal-03980588 , version 1 (02-03-2023)

Identifiants

Citer

Maxime Mallet, Victor Desplats, Charlotte Bouzbib, Philippe Sultanik, Imen Alioua, et al.. Blood ammonia in patients with chronic liver diseases: A better defined role in clinical practice. Analytical Biochemistry, 2022, 657, ⟨10.1016/j.ab.2022.114873⟩. ⟨hal-03980588⟩
10 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More